Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rouvier, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Daniel, L; Durbec, P; Gautherot, E; Rouvier, E; Rougon, G; Figarella-Branger, D
      A nude mice model of human rhabdomyosarcoma lung metastases for evaluatingthe role of polysialic acids in the metastatic process

      ONCOGENE
    2. de Labriolle-Vaylet, C; Cattan, P; Sarfati, E; Wioland, M; Billotey, C; Brocheriou, C; Rouvier, E; de Roquancourt, A; Rostene, W; Askienazy, S; Barbet, J; Milhaud, G; Gruaz-Guyon, A
      Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery

      CLINICAL CANCER RESEARCH
    3. Gautherot, E; Rouvier, E; Daniel, L; Loucif, E; Bouhou, J; Manetti, C; Martin, M; Le Doussal, JM; Barbet, J
      Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten

      JOURNAL OF NUCLEAR MEDICINE
    4. Gautherot, E; Kraeber-Bodere, F; Daniel, L; Fiche, M; Rouvier, E; Sai-Maurel, C; Thedrez, P; Chatal, JF; Barbet, J
      Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody

      CLINICAL CANCER RESEARCH
    5. Kraeber-Bodere, F; Bardet, S; Hoefnagel, CA; Vieira, MR; Vuillez, JP; Murat, A; Ferreira, TC; Bardies, M; Ferrer, L; Resche, I; Gautherot, E; Rouvier, E; Barbet, J; Chatal, JF
      Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial

      CLINICAL CANCER RESEARCH
    6. Vuillez, JP; Kraeber-Bodere, F; Moro, D; Bardies, M; Douillard, JY; Gautherot, E; Rouvier, E; Barbet, J; Garban, F; Moreau, P; Chatal, JF
      Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial

      CLINICAL CANCER RESEARCH
    7. BARBET J; PELTIER P; BARDET S; VUILLEZ JP; BACHELOT I; DENET S; OLIVIER P; LECCIA F; CORCUFF B; HUGLO D; PROYE C; ROUVIER E; MEYER P; CHATAL JF
      RADIOIMMUNODETECTION OF MEDULLARY-THYROID CARCINOMA USING IN-111 BIVALENT HAPTEN AND ANTI-CEA X ANTI-DTPA-INDIUM BISPECIFIC ANTIBODY

      The Journal of nuclear medicine
    8. LEGULUDEC D; NGUYEN C; PEKER C; BARDET J; MICHEL JB; ROUVIER E; PETIET A; SARDA L; PETEGNIEF Y; MEULEMANS A
      COMPARATIVE TARGETING OF EXPERIMENTAL INFARCTION USING ONE AND 2-STEPSYSTEMS

      The Journal of nuclear medicine
    9. BODERE FK; BARDET S; VUILLEZ JP; BARDIES M; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
      PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/

      The Journal of nuclear medicine
    10. GAUTHEROT E; LEDOUSSAL JM; BOUHOU J; MANETTI C; MARTIN M; ROUVIER E; BARBET J
      DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS

      The Journal of nuclear medicine
    11. ROUVIER E; GAUTHEROT E; MEYER P; BARBET J
      TARGETING MEDULLARY-THYROID CARCINOMAS WITH BISPECIFIC ANTIBODIES ANDBIVALENT HAPTENS - RESULTS AND CLINICAL PERSPECTIVES

      Hormone research
    12. GAUTHEROT E; BOUHOU J; LOUCIF E; MANETTI C; MARTIN M; LEDOUSSAL JW; ROUVIER E; BARBET J
      RADIOIMMUNOTHERAPY OF LS174T COLON-CARCINOMA IN NUDE-MICE USING AN IODINE-131-LABELED BIVALENT HAPTEN COMBINED WITH AN ANTI-CEA X ANTI-INDIUM-DTPA BISPECIFIC ANTIBODY

      The Journal of nuclear medicine
    13. VUILLEZ JP; MORO D; BRICHON PY; ROUVIER E; BRAMBILLA E; BARBET J; PELTIER P; MEYER P; SARRAZIN R; BRAMBILLA C
      2-STEP IMMUNOSCINTIGRAPHY FOR NON-SMALL-CELL LUNG-CANCER STAGING USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER/

      The Journal of nuclear medicine
    14. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; BARBET J; LEDOUSSAL JM
      TARGETING BCL1 LYMPHOMA WITH ANTIIDIOTYPE ANTIBODIES - BIODISTRIBUTION KINETICS OF DIRECTLY LABELED ANTIBODIES AND BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS

      International journal of cancer
    15. GAUTHEROT E; BOUHOU J; LEDOUSSAL JM; MANETTI C; MARTIN M; ROUVIER E; BARBET J
      THERAPY FOR COLON-CARCINOMA XENOGRAFTS WITH BISPECIFIC ANTIBODY-TARGETED, IODINE-131-LABELED BIVALENT HAPTEN

      Cancer
    16. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; LEDOUSSAL JM; MARTIN M; BARBET J
      RADIOIMMUNOTHERAPY OF BCL1 LYMPHOMA WITH BISPECIFIC ANTIBODIES AND IODINE-131-LABELED BIVALENT HAPTENS

      The Journal of nuclear medicine
    17. BARDIES M; BARDET S; FAIVRECHAUVET A; PELTIER P; DOUILLARD JY; MAHE M; FICHE M; LISBONA A; GIACALONE F; MEYER P; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
      BISPECIFIC ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN DOSIMETRY IN PATIENTS WITH MEDULLARY-THYROID OR SMALL-CELL LUNG-CANCER

      The Journal of nuclear medicine
    18. BENOMAR F; ROUVIER E; FAYN J; CAMBON A
      SYNTHESIS AND STRUCTURE OF F-ALKYLATED CY CLIC ETHYLENE SULFITES - PRECURSORS OF NEW FLUORINATED AMPHOTERIC SURFACTANTS

      Journal of fluorine chemistry
    19. FOSSIEZ F; DJOSSOU O; CHOMARAT P; FLORESROMO L; AITYAHIA S; MAAT C; PIN JJ; GARRONE P; GARCIA E; SAELAND S; BLANCHARD D; GAILLARD C; DASMAHAPATRA B; ROUVIER E; GOLSTEIN P; BANCHEREAU J; LEBECQUE S
      T-CELL INTERLEUKIN-17 INDUCES STROMAL CELLS TO PRODUCE PROINFLAMMATORY AND HEMATOPOIETIC CYTOKINES

      The Journal of experimental medicine
    20. DEVYS A; THEDREZ P; GAUTHEROT E; FAIVRECHAUVET A; SAIMAUREL C; ROUVIER E; AUGET JL; BARBET J; CHATAL JF
      COMPARATIVE TARGETING OF HUMAN COLON-CARCINOMA MULTICELL SPHEROIDS USING ONE-STEP AND 2-STEP (BISPECIFIC ANTIBODY) TECHNIQUES

      International journal of cancer
    21. MANETTI C; LEDOUSSAL JM; ROUVIER E; GRUAZGUYON A; BARBET J
      INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS

      International journal of cancer
    22. CHETANNEAU A; BARBET J; PELTIER P; LEDOUSSAL JM; GRUAZGUYON A; BERNARD AM; RESCHE I; ROUVIER E; BOURGUET P; DELAAGE M; CHATAL JF
      PRETARGETED IMAGING OF COLORECTAL-CANCER RECURRENCES USING AN IN-111-LABELED BIVALENT HAPTEN AND A BISPECIFIC ANTIBODY CONJUGATE

      Nuclear medicine communications
    23. BERTAINA B; ROUVIER E; FAYN J; CAMBON A
      SYNTHESIS AND REACTIVITY OF DI-(2-F-ALKYL ETHYLTHIO)METHANES AND THEIR OXIDATION-PRODUCTS .1. ALKYLATION

      Journal of fluorine chemistry
    24. ROUVIER E; LUCIANI MF; MATTEI MG; DENIZOT F; GOLSTEIN P
      CTLA-8, CLONED FROM AN ACTIVATED T-CELL, BEARING AU-RICH MESSENGER-RNA INSTABILITY SEQUENCES, AND HOMOLOGOUS TO A HERPESVIRUS SAIMIRI GENE

      The Journal of immunology
    25. BOLLENS E; TRABELSI H; FAYN J; ROUVIER E; CAMBON A
      SYNTHESIS OF F-ALKYL IMINOKETENES FOR PREPARATION OF F-ALKYL-BETA-AMIDO ESTERS SUBSTITUTED AT THE PSEUDO-MALONE POSITION

      Journal of fluorine chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:31:42